Tiffany, Kors to Re...
Health Care: Drugs
Johnson & Johnson (JNJ: NYSE)
$86.82 -0.39 | -0.45%
05/24/13 - 04:01 PM ET
10.39M / 9.88M
Vol / Avg. Vol:86.80 / 87.21
Open / Prev. Close:86.49 - 87.03
Today's Range:61.71 - 89.99
52 Wk Range:23.85%
Performance YTD:TheStreet Rating:
Portfolios with JNJ
- Portfolio NameUser Type
- Userralphd5-12
- UserQuicksilver55
- UserDC
- ProGeorge Soros
- UserSlip's Portfolio
- ContributorStocks Fund Managers Love Q...
- ContributorGame of Thrones Portfolio
- UserCapt Jer
- ContributorRocket Stocks for the Week ...
- ContributorShort Squeezes for the Week...
Latest JNJ Headlines from TheStreet
- An Investor's Choice: J&J or Baxter International? 04.19.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Haves and Have-Nots 04.17.13 | 08:04 pm
- 3 Stocks Advancing The Health Care Sector 04.17.13 | 01:04 pm
- Cramer's 6 Stocks in 60 Seconds: ESRX URI BBBY JNJ WDAY TGT 04.17.13 | 12:04 pm
- 5 Stocks Fund Managers Love for 2013 04.17.13 | 11:04 am
- Dow Today: Johnson & Johnson (JNJ) Leads The Day Higher, Bank Of America Corporation (BAC) Lags 04.17.13 | 10:04 am
- Google Offers Next Key Earnings Report 04.17.13 | 08:04 am
- Cramer's Top Stock Picks: KO JNJ GLD HK 04.17.13 | 06:04 am
- Dow Today: Johnson & Johnson (JNJ) Higher 04.16.13 | 11:04 am
- Morning Briefing: 10 Things You Should Know 04.16.13 | 08:04 am
Press Releases for JNJ
- Johnson & Johnson Pharmaceuticals Segment Poised To Continue Driving Growth With More Than 10 Potential New Product Filings By 2017 - PR Newswire 05.23.13 | 07:05 am
- Janssen And Johnson & Johnson To Provide Webcast Presentation Of Simeprevir Phase 3 Clinical Data Presented At The International Liver Congress Of The European Association For The Study Of The Liver (EASL) - PR Newswire 05.02.13 | 05:05 pm
- Johnson & Johnson Announces Dividend Increase Of 8.2% - PR Newswire 04.25.13 | 10:04 am
- Johnson & Johnson To Host Pharmaceuticals Business Review - PR Newswire 04.23.13 | 10:04 am
- Johnson & Johnson Announces Sale Of Elan American Depositary Shares To Elan - PR Newswire 04.18.13 | 09:04 am
- Johnson & Johnson To Webcast Annual Meeting Of Shareholders - PR Newswire 04.11.13 | 07:04 am
- Look And Feel Great This Spring, Despite Allergy Symptoms - PR Newswire 04.09.13 | 07:04 am
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Johnson & Johnson To Host Analyst Conference Call On First-Quarter Results - PR Newswire 03.19.13 | 10:03 am
- Cordis Acquires Flexible Stenting Solutions, Inc. - Business Wire 03.12.13 | 09:03 am
Partner Headlines for JNJ
- Companies slide $181B through tax loopholes - MSN Money 04.19.13 | 10:04 am
- Protect Yourself From Gold - Seeking Alpha 04.19.13 | 08:04 am
- Market Close Report: NASDAQ Composite index closes at 3,204.67 down -59.96 points - NASDAQ 04.17.13 | 08:04 pm
- Abbott Labs' Q1 Earnings Steady After AbbVie Spinoff - Investor's Business Daily 04.17.13 | 04:04 pm
- Questcor Pharmaceuticals, Inc. (QCOR) Ex-Dividend Date Scheduled for April 18, 2013 - NASDAQ 04.17.13 | 01:04 pm
- Dow up 158 as stocks stage a 'never-mind' rally - MSN Money 04.17.13 | 11:04 am
- The Dip's Been Bought, Now Prepare Or Despair - Seeking Alpha 04.17.13 | 09:04 am
- US corporate earnings boost Wall St - Financial Times 04.16.13 | 09:04 pm
- Biotech Alkermes Poised To Swell On Pipeline Wins - Investor's Business Daily 04.16.13 | 05:04 pm
- J&J Q1 Earnings Beat; Pharma Strong, Devices Weak - Investor's Business Daily 04.16.13 | 04:04 pm
